Furthermore, by directly addressing post-transcriptional dysregulation of PBX1 expression, patients who experience chronic or treatment-resistant psoriasis could potentially experience a reduction in both the severity and frequency of psoriatic episodes. Here, PBX1 is linked to psoriasis.